Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cell therapy in dilated cardiomyopathy].

Helena Furtado Martino1, Paulo Sérgio Oliveira, Edmilson Assunção

  • 1Hospital Prócardíaco, Instituto Nacional de Cardiologia Laranjeiras, Rio de Janeiro, RJ. hmartino@cardiol.br

Arquivos Brasileiros De Cardiologia
|June 6, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>MYH7</i> p.Glu903Gln Is a Pathogenic Variant Associated With Hypertrophic Cardiomyopathy.

Circulation. Genomic and precision medicine·2021
Same author

BK<sub>Ca</sub> Channel Activation Attenuates the Pathophysiological Progression of Monocrotaline-Induced Pulmonary Arterial Hypertension in Wistar Rats.

Cardiovascular drugs and therapy·2020
Same author

Different Signatures of High Cardiorespiratory Capacity Revealed With Metabolomic Profiling in Elite Athletes.

International journal of sports physiology and performance·2020
Same author

R534C mutation in hERG causes a trafficking defect in iPSC-derived cardiomyocytes from patients with type 2 long QT syndrome.

Scientific reports·2019
Same author

Echocardiographic Measurements in a Preclinical Model of Chronic Chagasic Cardiomyopathy in Dogs: Validation and Reproducibility.

Frontiers in cellular and infection microbiology·2019
Same author

Cardiac electrical and contractile disorders promoted by anabolic steroid overdose are associated with late autonomic imbalance and impaired Ca<sup>2+</sup> handling.

Steroids·2019

Autologous bone marrow cell transplant improved heart function in a patient with dilated cardiomyopathy. This pioneering procedure showed enhanced cardiac performance and reduced medication needs, with no adverse events.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Stem Cell Therapy

Background:

  • Dilated cardiomyopathy (DCM) is a severe heart condition characterized by left ventricular enlargement and systolic dysfunction.
  • Current treatments for advanced DCM often focus on managing symptoms and preventing further deterioration.
  • Autologous bone marrow cell transplantation is being explored as a potential regenerative therapy for heart failure.

Observation:

  • A 41-year-old male with NYHA FC-III, clinical stage C DCM underwent autologous bone marrow mononuclear cell transplantation via cardiac catheterization.
  • The procedure was performed using the coronary artery system for cell delivery.
  • The patient had no history of adverse events or hemodynamic instability prior to the procedure.

Findings:

Related Experiment Videos

  • Two months post-transplant, significant improvements were observed, including reduced plasma BNP levels and decreased cardiac area on chest X-ray and MRI.
  • Echocardiography revealed diminished secondary regurgitation and mitral ring dilatation.
  • Ergospirometry showed improved exercise capacity with increased maximal oxygen consumption, allowing for reduced medication.

    • Implications:

    • This case demonstrates the safety and feasibility of autologous bone marrow cell transplantation in treating dilated cardiomyopathy.
    • The observed improvements suggest potential for cardiac regeneration and functional recovery in heart failure patients.
    • This pioneering approach may offer a new therapeutic avenue for patients with advanced systolic heart failure.